Fortis Group Advisors’s Strata Critical Medical Inc SRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTA
AIM
NAMA
AIC
UIC
NRCM
Fortis Group Advisors's SRTA Position: Q1 2024 in Review
Fortis Group Advisors sold out of Strata Critical Medical Inc (SRTA) in Q1 2024, closing a stake of 17,807 shares — an estimated $60.2K sold.
Fortis Group Advisors first reported a position in SRTA in Q1 2023 and held it in 4 quarters. The position peaked at $69.7K in Q2 2023. 114 funds tracked by Wall St. Rank hold SRTA as of Q1 2024.
- Fortis Group Advisors reported no remaining Strata Critical Medical Inc position as of Q1 2024 after selling out during the quarter.
- Fortis Group Advisors sold 17,807 Strata Critical Medical Inc shares in Q1 2024, an estimated $60.2K.
- Fortis Group Advisors first reported a position in Strata Critical Medical Inc in Q1 2023 and held it in 4 quarters.
- Fortis Group Advisors's Strata Critical Medical Inc position peaked at $69.7K in Q2 2023.
- 114 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2024.
Based on Fortis Group Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.